Trouble Is Brewing For J&J's Covid Vaccine — What You Need To Know

Trouble Is Brewing For J&J's Covid Vaccine — What You Need To Know
ALLISON GATLIN
·2 min read

European regulators are investigating four cases of blood clots with low blood platelets in recipients of Johnson & Johnson's coronavirus vaccine. In response, JNJ stock dipped Friday.